BIOMAT Database Logo BIOMAT Database Logo

Effects of oxygen therapy on systemic inflammation and myeloperoxidase modified LDL in hypoxemic COPD patients. 2009

K Zouaoui Boudjeltia, and G Tragas, and S Babar, and A Moscariello, and V Nuyens, and P Van Antwerpen, and O Gilbert, and J Ducobu, and D Brohee, and M Vanhaeverbeek, and A Van Meerhaeghe

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D009195 Peroxidase A hemeprotein from leukocytes. Deficiency of this enzyme leads to a hereditary disorder coupled with disseminated moniliasis. It catalyzes the conversion of a donor and peroxide to an oxidized donor and water. EC 1.11.1.7. Myeloperoxidase,Hemi-Myeloperoxidase,Hemi Myeloperoxidase
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D010102 Oxygen Inhalation Therapy Inhalation of oxygen aimed at restoring toward normal any pathophysiologic alterations of gas exchange in the cardiopulmonary system, as by the use of a respirator, nasal catheter, tent, chamber, or mask. (From Dorland, 27th ed & Stedman, 25th ed) Inhalation Therapy, Oxygen,Therapy, Oxygen Inhalation,Inhalation Therapies, Oxygen,Oxygen Inhalation Therapies,Therapies, Oxygen Inhalation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016209 Interleukin-8 A member of the CXC chemokine family that plays a role in the regulation of the acute inflammatory response. It is secreted by variety of cell types and induces CHEMOTAXIS of NEUTROPHILS and other inflammatory cells. CXCL8 Chemokine,Chemokine CXCL8,Chemotactic Factor, Macrophage-Derived,Chemotactic Factor, Neutrophil, Monocyte-Derived,IL-8,Neutrophil-Activating Peptide, Lymphocyte-Derived,Neutrophil-Activating Peptide, Monocyte-Derived,AMCF-I,Alveolar Macrophage Chemotactic Factor-I,Anionic Neutrophil-Activating Peptide,Chemokines, CXCL8,Chemotactic Factor, Neutrophil,Granulocyte Chemotactic Peptide-Interleukin-8,IL8,Monocyte-Derived Neutrophil Chemotactic Factor,Neutrophil Activation Factor,Alveolar Macrophage Chemotactic Factor I,Anionic Neutrophil Activating Peptide,CXCL8 Chemokines,CXCL8, Chemokine,Chemokine, CXCL8,Chemotactic Factor, Macrophage Derived,Chemotactic Peptide-Interleukin-8, Granulocyte,Granulocyte Chemotactic Peptide Interleukin 8,Interleukin 8,Lymphocyte-Derived Neutrophil-Activating Peptide,Macrophage-Derived Chemotactic Factor,Monocyte-Derived Neutrophil-Activating Peptide,Neutrophil Activating Peptide, Lymphocyte Derived,Neutrophil Activating Peptide, Monocyte Derived,Neutrophil Chemotactic Factor,Neutrophil-Activating Peptide, Anionic,Peptide, Anionic Neutrophil-Activating
D016212 Transforming Growth Factor beta A factor synthesized in a wide variety of tissues. It acts synergistically with TGF-alpha in inducing phenotypic transformation and can also act as a negative autocrine growth factor. TGF-beta has a potential role in embryonal development, cellular differentiation, hormone secretion, and immune function. TGF-beta is found mostly as homodimer forms of separate gene products TGF-beta1, TGF-beta2 or TGF-beta3. Heterodimers composed of TGF-beta1 and 2 (TGF-beta1.2) or of TGF-beta2 and 3 (TGF-beta2.3) have been isolated. The TGF-beta proteins are synthesized as precursor proteins. Bone-Derived Transforming Growth Factor,Platelet Transforming Growth Factor,TGF-beta,Milk Growth Factor,TGFbeta,Bone Derived Transforming Growth Factor,Factor, Milk Growth,Growth Factor, Milk
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D018384 Oxidative Stress A disturbance in the prooxidant-antioxidant balance in favor of the former, leading to potential damage. Indicators of oxidative stress include damaged DNA bases, protein oxidation products, and lipid peroxidation products (Sies, Oxidative Stress, 1991, pxv-xvi). Anti-oxidative Stress,Antioxidative Stress,DNA Oxidative Damage,Nitro-Oxidative Stress,Oxidative Cleavage,Oxidative DNA Damage,Oxidative Damage,Oxidative Injury,Oxidative Nitrative Stress,Oxidative Stress Injury,Oxidative and Nitrosative Stress,Stress, Oxidative,Anti oxidative Stress,Anti-oxidative Stresses,Antioxidative Stresses,Cleavage, Oxidative,DNA Damage, Oxidative,DNA Oxidative Damages,Damage, DNA Oxidative,Damage, Oxidative,Damage, Oxidative DNA,Injury, Oxidative,Injury, Oxidative Stress,Nitrative Stress, Oxidative,Nitro Oxidative Stress,Nitro-Oxidative Stresses,Oxidative Cleavages,Oxidative DNA Damages,Oxidative Damage, DNA,Oxidative Damages,Oxidative Injuries,Oxidative Nitrative Stresses,Oxidative Stress Injuries,Oxidative Stresses,Stress Injury, Oxidative,Stress, Anti-oxidative,Stress, Antioxidative,Stress, Nitro-Oxidative,Stress, Oxidative Nitrative,Stresses, Nitro-Oxidative

Related Publications

K Zouaoui Boudjeltia, and G Tragas, and S Babar, and A Moscariello, and V Nuyens, and P Van Antwerpen, and O Gilbert, and J Ducobu, and D Brohee, and M Vanhaeverbeek, and A Van Meerhaeghe
Acute effects of oxygen treatment upon information processing in hypoxemic COPD patients.
August 1985, Chest,
K Zouaoui Boudjeltia, and G Tragas, and S Babar, and A Moscariello, and V Nuyens, and P Van Antwerpen, and O Gilbert, and J Ducobu, and D Brohee, and M Vanhaeverbeek, and A Van Meerhaeghe
Long-term oxygen therapy for COPD. Improving longevity and quality of life in hypoxemic patients.
April 1998, Postgraduate medicine,
K Zouaoui Boudjeltia, and G Tragas, and S Babar, and A Moscariello, and V Nuyens, and P Van Antwerpen, and O Gilbert, and J Ducobu, and D Brohee, and M Vanhaeverbeek, and A Van Meerhaeghe
Effect of oxygen therapy on increasing PaO2 in hypoxemic patients with stable COPD while breathing ambient air.
October 1992, Chest,
K Zouaoui Boudjeltia, and G Tragas, and S Babar, and A Moscariello, and V Nuyens, and P Van Antwerpen, and O Gilbert, and J Ducobu, and D Brohee, and M Vanhaeverbeek, and A Van Meerhaeghe
Effect of oxygen therapy on increasing PaO2 in hypoxemic patients with stable COPD while breathing ambient air.
October 1992, Chest,
K Zouaoui Boudjeltia, and G Tragas, and S Babar, and A Moscariello, and V Nuyens, and P Van Antwerpen, and O Gilbert, and J Ducobu, and D Brohee, and M Vanhaeverbeek, and A Van Meerhaeghe
The effects of nitrazepam and flunitrazepam on oxygen desaturation during sleep in patients with stable hypoxemic nonhypercapnic COPD.
April 1989, Chest,
K Zouaoui Boudjeltia, and G Tragas, and S Babar, and A Moscariello, and V Nuyens, and P Van Antwerpen, and O Gilbert, and J Ducobu, and D Brohee, and M Vanhaeverbeek, and A Van Meerhaeghe
The effect of low flow oxygen therapy on the chemical control of ventilation in patients with hypoxemic COPD.
December 1980, The American review of respiratory disease,
K Zouaoui Boudjeltia, and G Tragas, and S Babar, and A Moscariello, and V Nuyens, and P Van Antwerpen, and O Gilbert, and J Ducobu, and D Brohee, and M Vanhaeverbeek, and A Van Meerhaeghe
Inflammation in COPD: pathogenesis, local and systemic effects.
January 2011, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie,
K Zouaoui Boudjeltia, and G Tragas, and S Babar, and A Moscariello, and V Nuyens, and P Van Antwerpen, and O Gilbert, and J Ducobu, and D Brohee, and M Vanhaeverbeek, and A Van Meerhaeghe
Effects of Ovariohysterectomy and Hyperbaric Oxygen Therapy on Systemic Inflammation and Oxidation in Dogs.
January 2019, Frontiers in veterinary science,
K Zouaoui Boudjeltia, and G Tragas, and S Babar, and A Moscariello, and V Nuyens, and P Van Antwerpen, and O Gilbert, and J Ducobu, and D Brohee, and M Vanhaeverbeek, and A Van Meerhaeghe
Short term oxygen therapy effects in hypoxemic patients measured by drawing analysis.
March 2015, Computer methods and programs in biomedicine,
K Zouaoui Boudjeltia, and G Tragas, and S Babar, and A Moscariello, and V Nuyens, and P Van Antwerpen, and O Gilbert, and J Ducobu, and D Brohee, and M Vanhaeverbeek, and A Van Meerhaeghe
The effects of hypoxia on markers of coagulation and systemic inflammation in patients with COPD.
July 2010, Chest,
Copied contents to your clipboard!